FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barbara Scappini

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Phenomena

Phosphorylation

Physiology

Genes & Molecular Sequences

Genes, abl

Procedures

Co-author Network

Publications

TOP 3
Barbara Scappini; Federico Simonetti; Maria Chiara Susini; Emanuele Angelucci; Caterina Biagiotti; Lorenza Borin; Francesco Caracciolo; Ilaria Cutini; Rosa Fanci; Giacomo Gianfaldoni; Giovanni Longo; Francesco Mannelli; Enrico M Pogliani; Claudio Romani; Alberto Bosi
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients.
Irene Donnini; Stefano Guidi; Giovanni Longo; Barbara Scappini; Alberto Bosi
Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation.
Lisa Pieri; Barbara Scappini; Ambra Spolverini; Francesco Albano; Silvia Birtolo; Alberto Bosi; Carmen Fava; Umberto Occhini; Alessandro M Vannucchi
Concomitant occurrence of BCR-ABL and JAK2V617F mutation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barbara Scappini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Barbara Scappini; Federico Simonetti; Maria Chiara Susini; Emanuele Angelucci; Caterina Biagiotti; Lorenza Borin; Francesco Caracciolo; Ilaria Cutini; Rosa Fanci; Giacomo Gianfaldoni; Giovanni Longo; Francesco Mannelli; Enrico M Pogliani; Claudio Romani; Alberto Bosi
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients.
American journal of hematology 2012;87(12):1047-51.
2012: Irene Donnini; Stefano Guidi; Giovanni Longo; Barbara Scappini; Alberto Bosi
Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation.
Annals of hematology 2012;91(3):475-6.
2011: Lisa Pieri; Barbara Scappini; Ambra Spolverini; Francesco Albano; Silvia Birtolo; Alberto Bosi; Carmen Fava; Umberto Occhini; Alessandro M Vannucchi
Concomitant occurrence of BCR-ABL and JAK2V617F mutation.
Blood 2011;118(12):3445-6.
2006: Nada Orsolic; Mirna Golemovic; Alfonso Quintás-Cardama; Barbara Scappini; Taghi Manshouri; Joya Chandra; Ivan Basic; Francis Giles; Andrew Lamb; Srdan Verstovsek
Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.
Cancer science 2006;97(9):952-60.
2006: Monica Biscardi; Elisabetta Teodori; Roberto Caporale; Roberta Budriesi; Francesca Balestri; Barbara Scappini; Sabrina Gavazzi; Alberto Grossi
Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.
Leukemia research 2006;30(1):1-8.
2005: Riccardo Saccardi; Giovanni Luigi Mancardi; Alessandra Solari; Alberto Bosi; Paolo Bruzzi; Paolo Di Bartolomeo; Amedea Donelli; Massimo Filippi; Angelo Guerrasio; Francesca Gualandi; Giorgio La Nasa; Alessandra Murialdo; Francesca Pagliai; Federico Papineschi; Barbara Scappini; Alberto M Marmont
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.
Blood 2005;105(6):2601-7.
2004: Barbara Scappini; Simona Gatto; Francesco Onida; Clara Ricci; Vladimir Divoky; William G Wierda; Michael Andreeff; Li Dong; Kimberly Hayes; Srdan Verstovsek; Hagop M Kantarjian; Miloslav Beran
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.
Cancer 2004;100(7):1459-71.
2003: Simona Gatto; Barbara Scappini; Lan V Pham; Francesco Onida; Michele Milella; Greg Ball; Clara Ricci; Vladimir Divoky; Srdan Verstovsek; Hagop M Kantarjian; Michael J Keating; Jorge E Cortes-Franco; Miloslav Beran
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Haematologica 2003;88(8):853-63.
2003: Valeria Santini; Barbara Scappini; Zena K Indik; Antonella Gozzini; Pierluigi Rossi Ferrini; Alan D Schreiber
The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal.
Blood 2003;101(11):4615-22.
2002: Valeria Santini; Barbara Scappini; Alberto Grossi; Antonella Gozzini; Laura Bonsi; Gabriella Pagliai; Pierluigi Rossi Ferrini; Gian Paolo Bagnara
Lyn kinase is activated following thrombopoietin stimulation of the megakaryocytic cell line B1647.
Haematologica 2002;87(12):1242-7.
2002: Clara Ricci; Barbara Scappini; Vladimir Divoky; Simona Gatto; Francesco Onida; Srdan Verstovsek; Hagop M Kantarjian; Miloslav Beran
Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line.
Cancer research 2002;62(21):5995-8.
2002: Francesco Onida; Greg Ball; Hagop M Kantarjian; Terry L Smith; Armand B. Glassman; Maher Albitar; Barbara Scappini; Mary Beth Rios; Michael J Keating; Miloslav Beran
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Cancer 2002;95(8):1673-84.
2002: Barbara Scappini; Francesco Onida; Hagop M Kantarjian; Li Dong; Srdan Verstovsek; Michael J Keating; Miloslav Beran
In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells.
Cancer 2002;94(10):2653-62.
2001: Barbara Scappini; Francesco Onida; Hagop M Kantarjian; Li Dong; Srdan Verstovsek; Michael J Keating; Miloslav Beran
Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3884-93.
2001: Valeria Santini; Antonella Gozzini; Barbara Scappini; Alberto Grossi; Pierluigi Rossi Ferrini
Searching for the magic bullet against cancer: the butyrate saga.
Leukemia & lymphoma 2001;42(3):275-89.
1999: Valeria Santini; Antonella Gozzini; Barbara Scappini; Roberto Caporale; A Zoccolante; Luigi Rigacci; E Gelardi; Alberto Grossi; Renato Alterini; Pierluigi Rossi Ferrini
Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
Haematologica 1999;84(10):897-904.
1999: Valeria Santini; Antonella Gozzini; Barbara Scappini; Pierluigi Rossi Ferrini
Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation.
Haematologica 1999;84(4):291-7.
1999: P Pouillart; O Douillet; Barbara Scappini; Antonella Gozzini; Valeria Santini; Alberto Grossi; Gabriella Pagliai; Pierluigi Strippoli; Luigi Rigacci; G Ronco; P Villa
Regioselective synthesis and biological profiling of butyric and phenylalkylcarboxylic esters derivated from D-mannose and xylitol: influence of alkyl chain length on acute toxicity.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;7(2):93-106.
1998: Valeria Santini; Barbara Scappini; Antonella Gozzini; Alberto Grossi; P Villa; G Ronco; O Douillet; P Pouillart; Pietro Antonio Bernabei; Pierluigi Rossi Ferrini
Butyrate-stable monosaccharide derivatives induce maturation and apoptosis in human acute myeloid leukaemia cells.
British journal of haematology 1998;101(3):529-38.
1997: Valeria Santini; A Bernabei; Antonella Gozzini; Barbara Scappini; A Zoccolante; Gianluca D'Ippolito; M Figuccia; Pierluigi Rossi Ferrini
Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
Haematologica 1997;82(1):11-5.